Schwarz To Push For Damages In Univasc Patent Suit Vs. Teva
German drug maker Schwarz Pharma will continue to seek damages from Israel's Teva in a patent dispute over Schwarz's hypertension drug Univasc, even though Teva agreed to pull its supply of...To view the full article, register now.
Already a subscriber? Click here to view full article